Key result
GLP-1 peptides and exendin-4 improve left ventricular contractility and relaxation in diabetic rat hearts.
Why the study?
Although GLP-1 receptor ligands have demonstrated cardioprotective effects beyond glycemic control, their direct effects and those of sitagliptin on myocardial function in isolated diabetic rat hearts required investigation.
Do GLP-1 receptor ligands and sitagliptin directly improve ex vivo myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats?
Do GLP-1 receptor ligands and sitagliptin directly improve ex vivo myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats?
GLP-1 receptor ligands (GLP-1 7–36, GLP-1 9–36, and exendin-4) directly and partially improve impaired left ventricular contractility and relaxation in isolated diabetic rat hearts without altering heart rate, whereas sitagliptin and other classes of oral antidiabetic drugs do not exert acute direct inotropic or lusitropic effects.
Answers are grounded in this paper and cite their sources.
GLP-1 receptor ligands may directly improve contractility in diabetic rat hearts; hypothesis-generating for human diabetic cardiomyopathy pending clinical trials.
Purpose Glucagon-like peptide-1 (GLP-1) receptor ligands are widely used for the treatment of type 2 diabetes mellitus and obesity and have demonstrated cardioprotective effects beyond glycemic control. This study investigated the direct effects of GLP-1 receptor ligands and the dipeptidyl peptidase-4 inhibitor sitagliptin on myocardial function in isolated hearts from streptozotocin-induced diabetic rats. Methods Diabetes was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (50 mg/kg). Hearts from control and diabetic rats were retrogradely perfused for 30 min using a Langendorff system with GLP-1 (7–36), GLP-1 (9–36), exendin-4 (1–39), sitagliptin, glimepiride, pioglitazone, or metformin. Cardiac functional parameters, plasma total and active GLP-1 concentrations and serum total antioxidant status (TAS), total oxidant status (TOS), total sulfhydryl groups (TSG), advanced oxidation protein products (AOPP), and ischemia-modified albumin (IMA) were assessed. Results Diabetic hearts exhibited significantly lower heart rates and impaired left ventricular contractility and relaxation, indicated by reduced left ventricular + dP/dt max and -dP/dt min values, compared with controls. GLP-1 (7–36), GLP-1 (9–36), and exendin-4 (1–39) partially improved contractility and relaxation. Compared with controls, diabetic rats exhibited significantly higher plasma total and active GLP-1 concentrations, increased serum TOS and AOPP levels, and reduced TSG levels, whereas serum TAS and IMA levels remained unchanged. Conclusion These findings suggest that GLP-1 receptor ligands partially improve myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats, although the mechanisms underlying these effects remain to be elucidated.
No takes yet. Share an insight, caveat, or question.
Akcabag et al. (2026) studied Streptozotocin-induced diabetes mellitus (n=189). GLP-1 (7-36), GLP-1 (9-36), exendin-4 (1-39), sitagliptin, glimepiride, pioglitazone, or metformin vs. Basal levels and vehicle-treated control rat hearts was evaluated on Left ventricular contractility (+dP/dtmax) and relaxation (-dP/dtmin) in isolated perfused hearts. GLP-1 (7-36), GLP-1 (9-36), and exendin-4 (1-39) (10^-7 M) significantly improved impaired left ventricular +dP/dtmax and -dP/dtmin in isolated diabetic rat hearts during 30-min perfusion.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: